- Transplant was conducted at Massachusetts General Hospital and authorized by the U.S. FDA under a single Expanded Access protocol CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company ...
CAMBRIDGE, Mass., June 22, 2026--eGenesis Appoints Glenn S. Vraniak as Chief Financial Officer and Jennifer Bergheiser as Chief Commercial Officer ...
CEO & President Mike Curtis joins industry leaders to discuss the clinical progress and potential of xenotransplantation to address the global organ shortage eGenesis, a biotechnology company ...
Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started. Last Thursday, surgeons at ...
Morning Overview on MSN
The first US trials of gene-edited pig kidneys in patients are set to begin
Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
A man with end-stage renal disease is now healthy enough to be discharged from the hospital, after becoming the first in the world to receive a kidney transplant from a genetically engineered pig.
CAMBRIDGE, Mass. and IRVINE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- eGenesis, Inc. (“eGenesis”) and Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN ...
Biotechnology company eGenesis has raised $191 million in new venture capital to advance toward its first clinical trials after its genetically modified pig kidney was transplanted into a patient in a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the first ever transplantation ...
The appointments come as eGenesis advances in clinical studies across multiple programs, including EGEN-2784 for kidney failure and a program for acute-on-chronic liver failure, positioning the ...
CAMBRIDGE, Mass., June 18, 2026--(BUSINESS WIRE)--eGenesis, a biotechnology company developing human-compatible organs for transplantation, today announced that Michael Curtis, Ph.D., President and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results